World's Best Scientists 2026 revealed!
Alain Fourquet

Alain Fourquet

D-Index & Metrics

Medicine

D-Index
84
Citations
27090
World Ranking
15048
National Ranking
484

Overview

Alain Fourquet is affiliated with the Institute Curie in France. Their research primarily focuses on medical fields related to cancer, particularly breast cancer, and radiation therapy. Throughout their career, they have published extensively in areas intersecting medicine and biochemistry, genetics and molecular biology.

The main fields of study associated with their work include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

The subfields of their research encompass:

  • Cancer Research
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine
  • Radiation

The primary research topics they cover are:

  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Breast Lesions and Carcinomas
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • PARP inhibition in cancer therapy
  • BRCA gene mutations in cancer

Alain Fourquet has contributed to a number of recent papers, including:

  • Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial, 2020, The Lancet Oncology
  • Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer, 2022, JAMA Oncology
  • A Radiation Therapy Contouring Atlas for Cardiac Conduction Node Delineation, 2021, Practical Radiation Oncology
  • Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925, 2021, JNCI Journal of the National Cancer Institute

Throughout their career, the scientist has worked frequently with several co-authors, including:

  • Youlia Kirova
  • Pierre Loap
  • Kim Cao
  • F. Laki
  • Delphine Loirat

The common publication venues for Alain Fourquet's research include:

  • Cancer/Radiothérapie
  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Cancer Research
  • Cancers

Best Publications

  • Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

    Harry Bartelink;Jean-Claude Horiot;Philip M. Poortmans;Henk Struikmans

  • Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

    Harry Bartelink;Jean-Claude Horiot;Philip Poortmans;Henk Struikmans

  • Internal mammary and medial supraclavicular irradiation in breast cancer

    P.M.P. Poortmans;S. Collette;C. Kirkove;E. van Limbergen

  • Male breast cancer

    Ian S Fentiman;Alain Fourquet;Gabriel N Hortobagyi

  • Age as prognostic factor in premenopausal breast carcinoma.

    A. de la Rochefordière;F. Campana;J. Fenton;J.R. Vilcoq

  • Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

    Harry Bartelink;Philippe Maingon;Philip Poortmans;Caroline Weltens

  • Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up.

    Alain Fourquet;François Campana;Brigitte Zafrani;Véronique Mosseri

  • Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

    S.M. Scholl;A. Fourquet;B. Asselain;J.Y. Pierga

  • The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial

    Conny Vrieling;Laurence Collette;Alain Fourquet;Willem J. Hoogenraad

  • Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.

    L. J. Solin;J. Kurtz;A. Fourquet;R. Amalric

  • Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer

    P.A. Cabanes;R.J. Salmon;J.R. Vilcoq;J.C. Durand

  • Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

    Elisabeth Luporsi;Fabrice André;Frédérique Spyratos;Pierre-Marie Martin

  • The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer.

    Fatima Cardoso;Sibylle Loibl;Olivia Pagani;Alessandra Graziottin

  • Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

    Heather A. Jones;Ninja Antonini;Augustinus A.M. Hart;Johannes L. Peterse

  • Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.

    Christine Louis-Sylvestre;Krishna Clough;Bernard Asselain;Jacques René Vilcoq

  • Is obesity an independent prognosis factor in woman breast cancer

    Bilal Majed;Thierry Moreau;Kamel Senouci;Rémi J. Salmon

  • Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

    Sandra Collette;Laurence Collette;Tom Budiharto;Jean-Claude Horiot

  • Contralateral breast cancer: annual incidence and risk parameters.

    P Broët;A de la Rochefordière;S M Scholl;A Fourquet

  • Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

    Dominique Stoppa-Lyonnet;Yan Ansquer;Hélène Dreyfus;Chantal Gautier

  • O-113 Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the Randomized Boost Versus No Boost EORTC 22881–10882 Trial

    H. Struikmans;H. Bartelink;J.C. Horiot;P.M. Poortmans

Frequent Co-Authors

Bernard Asselain
Bernard Asselain Institute Curie
Anne Vincent-Salomon
Anne Vincent-Salomon Institute Curie
Xavier Sastre-Garau
Xavier Sastre-Garau Institute Curie
Harry Bartelink
Harry Bartelink Antoni van Leeuwenhoek Hospital
Philip Poortmans
Philip Poortmans University of Antwerp
Jean-Yves Pierga
Jean-Yves Pierga Institute Curie
Laurence Collette
Laurence Collette European Organisation for Research and Treatment of Cancer
Véronique Diéras
Véronique Diéras Institute Curie
Olivier Delattre
Olivier Delattre PSL University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career pathways related to medicine in the USA reveals several flexible online options. For those seeking a fast track to advanced nursing roles, direct entry np programs for non nurses online are becoming increasingly popular. These programs allow individuals without a nursing background to quickly gain specialized qualifications.

If you're just starting out, you might be interested in the easiest nursing programs to get into. These institutions provide accessible routes for students who may not meet all the traditional entry requirements but still want to pursue a rewarding healthcare career.

Not all healthcare-related paths require years of study. For example, those interested in the administrative side of medicine can find reputable medical billing and coding schools that accept fafsa, making education more affordable with financial aid options.

Finally, some nursing programs offer greater flexibility in admissions criteria. If you want to skip standardized entry exams, consider a nursing school that doesn't require teas testing, which can simplify your application process.

Best Scientists Citing Alain Fourquet

Trending Scientists